Literature DB >> 16778802

Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes.

Nahoko Komatsu, Yasushi Suga, Kiyofumi Saijoh, Amber C Liu, Saba Khan, Yuki Mizuno, Shigaku Ikeda, Hua-Kang Wu, Arumugam Jayakumar, Gary L Clayman, Fumiaki Shirasaki, Kazuhiko Takehara, Eleftherios P Diamandis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778802     DOI: 10.1038/sj.jid.5700379

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

3.  Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease.

Authors:  Vinzenz Oji; Katja-Martina Eckl; Karin Aufenvenne; Marc Nätebus; Tatjana Tarinski; Katharina Ackermann; Natalia Seller; Dieter Metze; Gudrun Nürnberg; Regina Fölster-Holst; Monika Schäfer-Korting; Ingrid Hausser; Heiko Traupe; Hans Christian Hennies
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

4.  Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.

Authors:  Azza Eissa; Vanessa Amodeo; Christopher R Smith; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

5.  Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases.

Authors:  Ulf Meyer-Hoffert; Zhihong Wu; Tomasz Kantyka; Jan Fischer; Ties Latendorf; Britta Hansmann; Joachim Bartels; Yinghong He; Regine Gläser; Jens-Michael Schröder
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 6.  Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.

Authors:  Sang Eun Lee; Se Kyoo Jeong; Seung Hun Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

Review 7.  The Itch-Scratch Cycle: A Neuroimmune Perspective.

Authors:  Madison R Mack; Brian S Kim
Journal:  Trends Immunol       Date:  2018-11-21       Impact factor: 16.687

8.  Inhibition of transcription factor specificity protein 1 alters the gene expression profile of keratinocytes leading to upregulation of kallikrein-related peptidases and thymic stromal lymphopoietin.

Authors:  Lianghua Bin; Byung E Kim; Clifton F Hall; Sonia M Leach; Donald Y M Leung
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

9.  Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases.

Authors:  Alisha M Smith; Nathan Harper; Justin A Meunier; Anne P Branum; Fabio Jimenez; Lavanya Pandranki; Andrew Carrillo; Charles S Dela Cruz; Marcos I Restrepo; Diego J Maselli; Cynthia G Rather; Anna H Heisser; Daniel A Ramirez; Weijing He; Robert A Clark; Charles P Andrews; Scott E Evans; Jacqueline A Pugh; Nu Zhang; Grace C Lee; Alvaro G Moreira; Leopoldo N Segal; Robert M Ramirez; Robert L Jacobs; Muthu Saravanan Manoharan; Jason F Okulicz; Sunil K Ahuja
Journal:  J Allergy Clin Immunol       Date:  2021-01-23       Impact factor: 14.290

10.  Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.

Authors:  Ulf Meyer-Hoffert; Zhihong Wu; Jens-Michael Schröder
Journal:  PLoS One       Date:  2009-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.